Household-level effects of seasonal malaria chemoprevention in the Gambia [PDF]
Communications MedicineBackground In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years.
Seyi Soremekun +11 more
doaj +2 more sources
A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda [PDF]
Gates Open Res, 2023 Richard Kajubi +12 more
openalex +2 more sources
Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso [PDF]
PLoS ONE, 2023 Seasonal Malaria chemoprevention (SMC) is one of the large-scale life-saving malaria interventions initially recommended for the Sahel subregion, including Burkina Faso and recently extended to other parts of Africa.
Paul Sondo +13 more
doaj +2 more sources
Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria [PDF]
Malaria JournalBackground As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns.
Taiwo Ibinaiye +8 more
doaj +2 more sources
A proposed method of grading malaria chemoprevention efficacy [PDF]
, 2023 The efficacy and effectiveness of antimalarial drugs are threatened by increasing levels of resistance and therefore require continuous monitoring. Chemoprevention is increasingly deployed as a malaria control measure, but there are no generally accepted
Bonnington, C, Nosten, Fh, White, NJ
core +2 more sources
Modelling the public health impact of second-generation malaria vaccines [PDF]
, 2022 Despite significant progress in the control and elimination of malaria over the past two decades, the global burden remains high. The COVID-19 pandemic has seen malaria cases and deaths increase markedly over 2019 resulting in 241 million malaria cases ...
Thompson, Hayley Adelaide
core +1 more source
Bulletin of the National Research Centre, 2023 Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi +11 more
doaj +1 more source
Malaria chemoprevention and drug resistance: a review of the literature and policy implications
Malaria Journal, 2022 Chemoprevention strategies reduce malaria disease and death, but the efficacy of anti-malarial drugs used for chemoprevention is perennially threatened by drug resistance.
Christopher V. Plowe
doaj +1 more source
From efficacy to effectiveness: a comprehensive framework for monitoring, evaluating and optimizing seasonal malaria chemoprevention programmes [PDF]
Malar JMonica Anna de Cola +13 more
openalex +2 more sources